Biochemical identification and crystal structure of kynurenine formamidase from Drosophila melanogaster
Results are expressed as a percentage of 5-mC
GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide
With its blend of expert care and patient-focused services, Klinic is the perfect choice for managing weight loss with tirzepatide in Orlando, Florida
Starting at 0.25mg weekly for the first four weeks, then increasing to 0.5mg for weeks 5-8, then to 1mg for weeks 9-12, and continuing to step up through 1.7mg and 2.4mg at four-week intervals
TROPION-Lung02: datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) in advanced non-small cell lung cancer (aNSCLC)